Unique stem cell line identifier | TRNDi003-A |
Alternative name(s) of stem cell line | HT215A |
Institution | National Institutes of Health National Center for Advancing Translational Sciences Bethesda, Maryland, USA |
Contact information of distributor | Dr. Wei Zheng Wei.Zheng@nih.gov |
Type of cell line | iPSC |
Origin | Human |
Additional origin info | Age: 13-year-old Sex: Female Ethnicity: Somalian |
Cell Source | Peripheral blood mononuclear cells (PBMCs) |
Clonality | Clonal |
Method of reprogramming | Integration-free Sendai viral vectors |
Genetic Modification | NO |
Type of Modification | N/A |
Associated disease | Noonan syndrome with multiple lentigines (NSML) |
Gene/locus | PTPN11Q510P |
Method of modification | N/A |
Name of transgene or resistance | N/A |
Inducible/constitutive system | N/A |
Date archived/stock date | 03-26-2017 |
Cell line repository/bank | Human Pluripotent Stem Cell Registry https://hpscreg.eu/cell-line/TRNDi003-A |
Ethical approval | Completed under Boston Children’s Hospital IRB Protocol 08-05-0208 |